Skip to main content
Log in

Activation of CXCL10/CXCR3 Signaling Attenuates Morphine Analgesia: Involvement of Gi Protein

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Morphine is a potent agonist of μ-opioid receptor and is widely used to relieve severe pain, including cancer pain. Some chemokines, for example, CX3CL1 and CCL2, participate in the regulation of opioid santinociception. In our previous study, we found overexpression of chemokine CXCL10/CXCR3 in spinal cord participated in the development of cancer-induced bone pain, so we supposed that CXCL10 may have influence in morphine analgesia in cancer pain relief. In this study, we found that a single dose of morphine could transiently increase the expression of CXCL10 in spinal cord. Blocking the function of CXCL10 enhanced morphine antinociception in cancer-induced bone pain rats. However, overexpression of CXCL10 induced acute algesia and decreased the analgesic effect of morphine in normal mice. The algesic effect of CXCL10 was blocked by inhibition of CXCR3 and Gi protein. These results suggested that CXCL10 in spinal cord serves as a novel negative regulator of morphine analgesia and provided evidence that activation of CXCL10/CXCR3 in spinal cord may attenuate antinociceptive potency of morphine in cancer pain relief.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Akekawatchai C, Holland JD, Kochetkova M, Wallace JC, McColl SR (2005) Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells. J Biol Chem 280:39701–39708

    Article  CAS  PubMed  Google Scholar 

  • Belkouch M, Dansereau MA, Reaux-Le Goazigo A, Van Steenwinckel J, Beaudet N, Chraibi A, Melik-Parsadaniantz S, Sarret P (2011) The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a Gbetagamma-dependent mechanism. J Neurosci 31:18381–18390

    Article  CAS  PubMed  Google Scholar 

  • Bovill JG (1997) Mechanisms of actions of opioids and non-steroidal anti-inflammatory drugs. Eur J Anaesthesiol Suppl 15:9–15

    Article  CAS  PubMed  Google Scholar 

  • Bu H, Shu B, Gao F, Liu C, Guan X, Ke C, Cao F, Hinton AO, Jr., Xiang H, Yang H, Tian X, Tian Y (2013) Spinal IFN-gamma-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models. Breast Cancer Res Treat. doi:10.1007/s10549-013-2807-4

  • Cao F, Gao F, Xu AJ, Chen ZJ, Chen SS, Yang H, Yu HH, Mei W, Liu XJ, Xiao XP, Yang SB, Tian XB, Wang XR, Tian YK (2010) Regulation of spinal neuroimmune responses by prolonged morphine treatment in a rat model of cancer induced bone pain. Brain Res 1326:162–173

    Article  CAS  PubMed  Google Scholar 

  • Chen X, Geller EB, Rogers TJ, Adler MW (2007) The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats. Brain Res 1153:52–57

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Dauvergne C, Molet J, Reaux-Le Goazigo A, Mauborgne A, Melik-Parsadaniantz S, Boucher Y, Pohl M (2013) Implication of the chemokine CCL2 in trigeminal nociception and traumatic neuropathic orofacial pain. Eur J Pain. doi:10.1002/j.1532-2149.2013.00377.x

    PubMed  Google Scholar 

  • Davis RL, Buck DJ, Saffarian N, Stevens CW (2007) The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells. J Neuroimmunol 186:141–149

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Harris TH, Banigan EJ, Christian DA, Konradt C, Tait Wojno ED, Norose K, Wilson EH, John B, Weninger W, Luster AD, Liu AJ, Hunter CA (2012) Generalized Levy walks and the role of chemokines in migration of effector CD8+ T cells. Nature 486:545–548

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hidalgo A, Sanz-Rodriguez F, Rodriguez-Fernandez JL, Albella B, Blaya C, Wright N, Cabanas C, Prosper F, Gutierrez-Ramos JC, Teixido J (2001) Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. Exp Hematol 29:345–355

    Article  CAS  PubMed  Google Scholar 

  • Hu JH, Yang JP, Liu L, Li CF, Wang LN, Ji FH, Cheng H (2012) Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord. Brain Res 1465:1–9

    Article  CAS  PubMed  Google Scholar 

  • Hylden JL, Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67:313–316

    Article  CAS  PubMed  Google Scholar 

  • Jackson KJ, Damaj MI (2013) Calcium/calmodulin-dependent protein kinase IV mediates acute nicotine-induced antinociception in acute thermal pain tests. Behav Pharmacol 24:689–692

    Article  CAS  PubMed  Google Scholar 

  • Ke C, Li C, Huang X, Cao F, Shi D, He W, Bu H, Gao F, Cai T, Hinton AO Jr, Tian Y (2013) Protocadherin20 promotes excitatory synaptogenesis in dorsal horn and contributes to bone cancer pain. Neuropharmacology 75C:181–190

    Article  Google Scholar 

  • Korniejewska A, McKnight AJ, Johnson Z, Watson ML, Ward SG (2011) Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Immunology 132:503–515

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Liu X, Bu H, Liu C, Gao F, Yang H, Tian X, Xu A, Chen Z, Cao F, Tian Y (2012) Inhibition of glial activation in rostral ventromedial medulla attenuates mechanical allodynia in a rat model of cancer-induced bone pain. J Huazhong Univ Sci Technolog Med Sci 32:291–298

    Article  CAS  PubMed  Google Scholar 

  • Loram LC, Grace PM, Strand KA, Taylor FR, Ellis A, Berkelhammer D, Bowlin M, Skarda B, Maier SF, Watkins LR (2012) Prior exposure to repeated morphine potentiates mechanical allodynia induced by peripheral inflammation and neuropathy. Brain Behav Immun 26:1256–1264

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Mao-Ying QL, Wang XW, Yang CJ, Li X, Mi WL, Wu GC, Wang YQ (2012) Robust spinal neuroinflammation mediates mechanical allodynia in Walker 256 induced bone cancer rats. Mol Brain 5:16

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Nguyen KD, Vanichsarn C, Fohner A, Nadeau KC (2009) Selective deregulation in chemokine signaling pathways of CD4 + CD25(hi)CD127(lo)/(−) regulatory T cells in human allergic asthma. J Allergy Clin Immunol 123(933–9):e10

    PubMed  Google Scholar 

  • Petreaca ML, Do D, Dhall S, McLelland D, Serafino A, Lyubovitsky J, Schiller N, Martins-Green MM (2012) Deletion of a tumor necrosis superfamily gene in mice leads to impaired healing that mimics chronic wounds in humans. Wound Repair Regen 20:353–366

    Article  PubMed Central  PubMed  Google Scholar 

  • Qin X, Wan Y, Wang X (2005) CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons. J Neurosci Res 82:51–62

    Article  CAS  PubMed  Google Scholar 

  • Rivat C, Sebaihi S, Steenwinckel JV, Fouquet S, Kitabgi P, Pohl M, Parsadaniantz SM, Goazigo AR (2013) Src family kinases involved in CXCL12-induced loss of acute morphine analgesia. Brain Behav Immun. doi:10.1016/j.bbi.2013.11.010

    PubMed  Google Scholar 

  • Sanchez-Sanchez N, Riol-Blanco L, de la Rosa G, Puig-Kroger A, Garcia-Bordas J, Martin D, Longo N, Cuadrado A, Cabanas C, Corbi AL, Sanchez-Mateos P, Rodriguez-Fernandez JL (2004) Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104:619–625

    Article  CAS  PubMed  Google Scholar 

  • Sano R, Tessitore A, Ingrassia A, d'Azzo A (2005) Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology. Blood 106:2259–2268

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Schwarz JM, Smith SH, Bilbo SD (2013) FACS analysis of neuronal–glial interactions in the nucleus accumbens following morphine administration. Psychopharmacology (Berl). doi:10.1007/s00213-013-3180-z

    Google Scholar 

  • Smit MJ, Verdijk P, van der Raaij-Helmer EM, Navis M, Hensbergen PJ, Leurs R, Tensen CP (2003) CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Blood 102:1959–1965

    Article  CAS  PubMed  Google Scholar 

  • Suzuki M, Narita M, Hasegawa M, Furuta S, Kawamata T, Ashikawa M, Miyano K, Yanagihara K, Chiwaki F, Ochiya T, Suzuki T, Matoba M, Sasaki H, Uezono Y (2012) Sensation of abdominal pain induced by peritoneal carcinomatosis is accompanied by changes in the expression of substance P and mu-opioid receptors in the spinal cord of mice. Anesthesiology 117:847–856

    Article  CAS  PubMed  Google Scholar 

  • Szabo I, Chen XH, Xin L, Adler MW, Howard OM, Oppenheim JJ, Rogers TJ (2002) Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci U S A 99:10276–10281

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wang LN, Yang JP, Ji FH, Zhan Y, Jin XH, Xu QN, Wang XY, Zuo JL (2012) Brain-derived neurotrophic factor modulates N-methyl-d-aspartate receptor activation in a rat model of cancer-induced bone pain. J Neurosci Res 90:1249–1260

    Article  CAS  PubMed  Google Scholar 

  • Weibel R, Reiss D, Karchewski L, Gardon O, Matifas A, Filliol D, Becker JA, Wood JN, Kieffer BL, Gaveriaux-Ruff C (2013) Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice. PLoS One 8:e74706

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Willox I, Mirkina I, Westwick J, Ward SG (2010) Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cells. Mol Immunol 47:2367–2377

    Article  CAS  PubMed  Google Scholar 

  • Yaksh TL, Rudy TA (1976) Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17:1031–1036

    Article  CAS  PubMed  Google Scholar 

  • Yoon Y, Liang Z, Zhang X, Choe M, Zhu A, Cho HT, Shin DM, Goodman MM, Chen ZG, Shim H (2007) CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models. Cancer Res 67:7518–7524

    Article  CAS  PubMed  Google Scholar 

  • Zhao CM, Guo RX, Hu F, Meng JL, Mo LQ, Chen PX, Liao XX, Cui Y, Feng JQ (2012) Spinal MCP-1 contributes to the development of morphine antinociceptive tolerance in rats. Am J Med Sci 344:473–479

    Article  PubMed  Google Scholar 

  • Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR (2007) Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 21:642–651

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the National Natural Science Foundation of the People's Republic of China (No. 81171259, No. 81371250, and No. 81070890) and also supported by 2010 Clinical Key Disciplines Construction Grant from the Ministry of Health of China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Feng Gao.

Additional information

Dawei Ye and Huilian Bu contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ye, D., Bu, H., Guo, G. et al. Activation of CXCL10/CXCR3 Signaling Attenuates Morphine Analgesia: Involvement of Gi Protein. J Mol Neurosci 53, 571–579 (2014). https://doi.org/10.1007/s12031-013-0223-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-013-0223-1

Keywords

Navigation